ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $299,467 | +61.9% | 176,157 | 0.0% | 0.00% | – |
Q2 2023 | $184,965 | -84.7% | 176,157 | -82.5% | 0.00% | – |
Q1 2023 | $1,209,442 | -60.0% | 1,007,868 | -50.0% | 0.00% | – |
Q4 2022 | $3,020,946 | +1.0% | 2,013,964 | +110.7% | 0.00% | – |
Q3 2022 | $2,992,000 | -2.4% | 956,042 | +2.2% | 0.00% | – |
Q2 2022 | $3,067,000 | -6.7% | 935,152 | +29.7% | 0.00% | – |
Q1 2022 | $3,289,000 | -72.1% | 721,192 | -55.6% | 0.00% | -100.0% |
Q4 2021 | $11,792,000 | -11.7% | 1,624,280 | +413.9% | 0.00% | 0.0% |
Q3 2021 | $13,351,000 | – | 316,078 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 6,398,250 | $20,986,000 | 23.53% |
Foresite Capital Management V, LLC | 1,431,826 | $4,696,000 | 3.28% |
Alphabet Inc. | 5,680,785 | $18,633,000 | 1.01% |
683 Capital Management, LLC | 3,603,637 | $11,820,000 | 0.84% |
Slate Path Capital LP | 3,735,000 | $12,251,000 | 0.76% |
Bain Capital Life Sciences Investors, LLC | 1,937,207 | $6,354,000 | 0.74% |
Rubric Capital Management LP | 1,812,347 | $5,944,000 | 0.31% |
Orbimed Advisors | 5,056,000 | $16,584,000 | 0.30% |
Newtyn Management, LLC | 400,875 | $1,315,000 | 0.25% |
Redmile Group, LLC | 1,920,960 | $6,301,000 | 0.24% |